






Vol.4 , No. 1, Publication Date: Jun. 13, 2017, Page: 1-4
[1] | Li Linfeng, Department of Traditional Chinese Medicine, Hebei University, Shijiazhuang, China. |
[2] | Zhao Bo, Department of Traditional Chinese Medicine, Hebei University, Shijiazhuang, China. |
[3] | Wang Yu, Department of Traditional Chinese Medicine, Hebei University, Shijiazhuang, China. |
[4] | Zhang Lanlan, Department of Traditional Chinese Medicine, Hebei University, Shijiazhuang, China. |
[5] | Wei Yanping, Department of Traditional Chinese Medicine, Hebei University, Shijiazhuang, China. |
[6] | Wang Haodong, Department of Nursing, Hebei University School of Medicine Department of Nursing, Hebei School of University Medicine, Shijiazhuang, China. |
[7] | Liu Nan, Department of Traditional Chinese Medicine, Hebei University, Shijiazhuang, China. |
[8] | Li Siqi, Department of Traditional Chinese Medicine, Hebei University, Shijiazhuang, China. |
[9] | Pu Yunge, Department of Traditional Chinese Medicine, Hebei University, Shijiazhuang, China. |
[10] | Chang Pengfei, Department of Traditional Chinese Medicine, Hebei University, Shijiazhuang, China. |
[11] | Zhang Guowei, Department of Traditional Chinese Medicine, Hebei University, Shijiazhuang, China. |
[12] | Qin Xiude, Shenzhen Chinese Traditional Medical Hospital, Guangzhou University of Chinese Medicine, Guangzhou, China. |
In order to study the content of procalcitonin (PCT) in rat model of stroke reperfusion, and explore the feasibility of PCT as a sensitive marker of stroke, model group and sham operation group were set. A rat model of focal cerebral ischemia was established by modified suture method, then pulled out a threaded portion after MCAO reperfusion 1 hour. And then to the rats to take blood abdomen, finally with ELISA method to detect PCT 24 h and 48 h serum PCT level in rats. The results showed that the level of serum PCT in model group was significantly higher than that in sham operation group, which confirmed that the rat serum PCT can be used as a marker of stroke one of the markers used to detect the symptoms of ischemic stroke in rats.
Keywords
Cerebral Ischemia Reperfusion, Rats, Procalcitonin
Reference
[01] | Huang Ru Xun et al. Type of stroke staging treatment recommendations (draft national Cerebrovascular Disease Symposium, Guangzhou 2000) [R]. Journal of Cinical Neurology, 2001. (01): 60-62. |
[02] | Wang Xiang, Zhou Liang. Determination and Clinical study of serum MCP-1 in patients with acute cerebral infarction [J]. Chinese Journal of Neurology, 2010.9 (2): 172-175. |
[03] | Jia Nan, Xiong Xiong. Research and Development of some biomarkers related to stroke [J]. Journal of Modern Laboratory Medicine, 2010.25 (5): 156-158. (in Chinese). |
[04] | Wei Lihong, Bai Jie, Chen, Shi Jiaoxia, Zheng Xianzhao. Procalcitonin CRP test in diagnosis of stroke associated pneumonia in value [J]. Chinese Journal of Practical Neurology, 2014.17 (16): 112-113. |
[05] | Neurology Cerebrovascular disease group of ischemic stroke in two grade prevention guidelines writing group of Chinese Medical Association. The two grade prevention guide 2010[J]. Chinese Journal of Neurology Chinese Ischemic Stroke and Transient Ischemic Attack, 2010.43 (2):154-160. |
[06] | Kotlega D, Nowacki P, Bialecka M, et al. Association between CRP gene polymorphism 717A/G,C-reactive protein and neurological deficit in ischemic stroke[J].J Clin Neurosci,2014.21(4):574-577. |
[07] | Bi Pengxiang, Tang Jianping, et al. Dynamic detection of serum procalcitonin level in patients with ICU stroke [J]. Journal of Qiqihar Medical School, 2011.32 (13): 2069-2071. |
[08] | Torres A, Ranmirez P, Montull B,et al. Biomarkers and Community-acquired pneumonia: tailoring management with biological date [J]. Semin Respir Care Med, 2012. 33(3): 266-271. |
[09] | Hu Ru Xue. The clinical application value of calcitonin (PCT) [J]. Medical Examination in Jiangxi, 2005. 23(3):259-244. |
[10] | Qiu Guanyang, Huang Dandan, Deng Yaofang, et al. Patients with severe stroke serum procalcitonin level and continuous monitoring of [J]. International Journal of Pharmaceutical Medicine, 2014.20 (10):1370-1373. |
[11] | Becker K L, Snideer R, Nylen E S. Procalcitionin in sepsis and systemic inflammation:a harmful biomarker and a therapeutic target [J]. Br J Pharmacol, 2010. 159(2):253-246. |
[12] | Wu Dongchuan, Yin Shihua, et al. The relationship between serum levels of HS-CRP and PCT in patients with stroke [J]. Journal of Practical Clinical Medicine, 2013.17 (24):27-30. |